Nu Skin Enterprises (NYSE:NUS) Releases Q4 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its fourth quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.19 to $0.29 for the period, compared to the consensus estimate of $0.28. The company issued revenue guidance of $410 million to $445 million, compared to the consensus revenue estimate of $455.83 million.

Nu Skin Enterprises Trading Down 0.5 %

Shares of NUS traded down $0.03 during trading hours on Thursday, hitting $6.45. 1,132,522 shares of the stock were exchanged, compared to its average volume of 844,760. Nu Skin Enterprises has a fifty-two week low of $5.95 and a fifty-two week high of $20.75. The business has a 50-day moving average of $6.95 and a 200-day moving average of $9.96. The firm has a market capitalization of $320.57 million, a P/E ratio of -2.17 and a beta of 1.14. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. The company had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The firm’s revenue for the quarter was down 12.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.54 EPS. On average, research analysts expect that Nu Skin Enterprises will post 0.78 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th. Citigroup dropped their price target on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. Finally, StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.